Mark Cuban: Pharma’s Secret Weapon In The Fight Against PBMs

 
• By Sarah Karlin-Smith

The well-known businessman and TV personality told the White House that the US needs to ‘stop doing business with the big three PBMs,’ helping to fight the drug industry’s battle against the middlemen with a friendlier face not associated directly with the brand industry.

Mark Cuban at White House on 4 March 2024
Mark Cuban was part of a White House panel on PBM issues that did not include any PBMs. • Source: Screenshot of White House feed

The pharmaceutical industry wasn’t directly represented at the White House’s pharmacy benefits management roundtable on 4 March, but their agenda – to put the onus of drug affordability challenges on PBMs – took center stage, offered by actors who likely make the industry’s messages more palatable.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from PBMs

More from Market Access